Effectiveness of integrase strand transfer inhibitors in HIV-infected treatment-experienced individuals across Europe

Funding Information: The INTEGRATE project received an unconditioned grant from Gilead Sciences Europe Ltd. This study was also funded by the Swedish Research Council (2016‐01675, to AS), the European Union by the CARE H2020 project (under grant agreement no. 825673) and Stockholm County Council (AL...

ver descrição completa

Detalhes bibliográficos
Autor principal: EuResist Network, INTEGRATE study group (author)
Outros Autores: Abecasis, Ana (author), Gomes, Perpetua (author), Vandamme, A. M. (author)
Formato: article
Idioma:eng
Publicado em: 2022
Assuntos:
dolutegravir
effectiveness
elvitegravir
HIV
INSTI
integrase strand transfer inhibitors
raltegravir
treatment-experienced
Health Policy
Infectious Diseases
Pharmacology (medical)
SDG 3 - Good Health and Well-being
Texto completo:http://hdl.handle.net/10362/143388
País:Portugal
Oai:oai:run.unl.pt:10362/143388

Texto Completo

http://hdl.handle.net/10362/143388

Registros relacionados